CMPS Q1 2026 Earnings Narrower Loss Drives Positive Investor Sentiment Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech CPF Q1 2026 Earnings EPS Beats Estimates by 44 Amid Solid Operating Performance HAFN Q4 2025 Earnings EPS Misses Estimates as Tanker Market Softens FRPT Q1 2026 Earnings A Deep EPS Miss Clouds Freshpets Growth Trajectory National Vision Holdings EYE Q1 2026 Earnings EPS Surprise Lifts Stock After Revenue Shortfall